0001437749-22-019620.txt : 20220809 0001437749-22-019620.hdr.sgml : 20220809 20220809162319 ACCESSION NUMBER: 0001437749-22-019620 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220805 FILED AS OF DATE: 20220809 DATE AS OF CHANGE: 20220809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Points Jeffrey S. CENTRAL INDEX KEY: 0001731414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 221148687 MAIL ADDRESS: STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC. STREET 2: 1225 OLD HIGHWAY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 4 1 rdgdoc.xml FORM 4 X0306 4 2022-08-05 0001180145 Cardiovascular Systems Inc CSII 0001731414 Points Jeffrey S. 1225 OLD HIGHWAY 8 NW ST. PAUL MN 55112 1 Chief Financial Officer Common Stock 2022-08-05 4 A 0 18916 0 A 128228 D Common Stock 2022-08-05 4 A 0 56747 0 A 184975 D Restrictions lapse as to 6,306 shares on 8/13/23 and as to 6,605 shares on each of 8/13/24 and 8/13/25. Subject to performance-based forfeiture of 28,374 shares based on the Company's three-year total shareholder return for fiscal years 2023, 2024 and 2025 versus the Company's peer group, and for 28,373 shares based on the Company's average annual revenue growth in fiscal years 2023, 2024 and 2025. /s/ Andrew Nick as Attorney-in-Fact for Jeffrey S. Points pursuant to Power of Attorney previously filed. 2022-08-09